defenceWeb Written by defenceWeb - A vial of Heberon. Feedback from one of three investigations underway into the acquisition, from Cuba, of an unregistered drug to prevent the spread of COVID-19 in the national defence force indicates at present no response from the SA National Defence Force (SANDF). A senior investigator at the Office of the Public Protector, responding to Democratic Alliance (DA) parliamentarian Kobus Marais on the investigation’s progress, said the SA Health Products Regulatory Authority (SAHPRA) answered an enquiry letter from the Chapter Nine institution as regards its involvement in the acquisition of Heberon. The shadow defence and military veterans minister was further informed the SA National Defence Force (SANDF), still under the leadership of General Solly Shoke, had not replied to the Public Protector enquiry.